Welcome to NuMedii – Revolutionizing Drug Discovery

Translating Big Data into New Medicines

Revolutionizing drug discovery by translating big data into pipeline drug candidates with a higher probability of success.

Numedii's Proprietary Big Data Platform

Integrative genomics, network-based methods, large-scale machine learning, chemoinformatics

Learn More

Innovative Technology

Innovative Technology

NuMedii’s Big Data Discovery Technology uses proprietary and proven integrative biology methods to identify new indications.

learn More

New Oppurtunities

New Opportunities

Put the power of Big Data Discovery Technology to work. We are seeking partnerships across therapeutic categories.

learn More

World Renowned Team

World Renowned Team

NuMedii is backed by a team comprised of world renowned scientists and biotechnology entrepreneurs.

learn More

Latest News

NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

The Scientist, January 2017 Issue, Repurposing Existing Drugs for New Indications

NuMedii Wins 2016 Bioprocess International Award For Emerging Company

More News

New Opportunities

NuMedii is creating pipeline drug candidates with a higher probability of therapeutic success. The Company uses its Life Sciences Big Data technology to translate novel disease-drug connections into new indications for existing drugs and optimal indications for NMEs. NuMedii partners with pharmaceutical companies for the clinical development and commercialization of its de-risked drug candidates.

Learn How

Home
Company
Technology
Partners
News & Events
Contact Us